Paper · 42979207

Liver-Lung Organotropism in Pancreatic Ductal Adenocarcinoma: A Five-Stage Framework.

Cong B and 3 others. Cancer Manag Res, 2026.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Liver-Lung Organotropism in Pancreatic Ductal Adenocarcinoma: A Five-Stage Framework. Papers, record 42979207. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42979207

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Liver-Lung Organotropism in Pancreatic Ductal Adenocarcinoma: A Five-Stage Framework.
Journal: Cancer Manag Res
Year: 2026
Publication types: Journal Article, Review
PubMed: https://pubmed.ncbi.nlm.nih.gov/42979207/
DOI: https://doi.org/10.2147/cmar.s644548
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC13730061/
The journal: https://conductscience.org/library/journal-index/101512700
Revised in PubMed: 2026-11-05

Source PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Cong B	Baodan
2	Deng K	Kunfei
3	Du Y	Yu
4	Sun K	Kaidi

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	28,092,686	Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis.	Nat Genet	2017	https://conductscience.org/library/papers/28092686	PubMed
2	37,678,671	Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.	Ann Oncol	2023	https://conductscience.org/library/papers/37678671	PubMed
3	24,856,585	Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.	Cancer Cell	2014	https://conductscience.org/library/papers/24856585	PubMed
4	26,560,028	Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.	Nature	2015	https://conductscience.org/library/papers/26560028	PubMed
5	31,483,448	Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial.	JAMA Surg	2019	https://conductscience.org/library/papers/31483448	PubMed
6	28,414,315	The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer.	Nat Cell Biol	2017	https://conductscience.org/library/papers/28414315	PubMed
7	35,740,692	The Liver Pre-Metastatic Niche in Pancreatic Cancer: A Potential Opportunity for Intervention.	Cancers (Basel)	2022	https://conductscience.org/library/papers/35740692	PubMed
8	29,675,723	Intratumoral Heterogeneity of SMAD4 Immunohistochemical Expression and Its Role in Prediction of Recurrence Pattern in Patients with Resectable Pancreatic Cancer.	J Gastrointest Cancer	2019	https://conductscience.org/library/papers/29675723	PubMed
9	28,790,031	BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer.	Cancer Discov	2017	https://conductscience.org/library/papers/28790031	PubMed
10	37,526,431	Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence.	Cancer Biol Ther	2023	https://conductscience.org/library/papers/37526431	PubMed

1 to 10 of 67

See all 67 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42979207

GET https://conductscience.org/api/papers/v1/42979207/references?page=2

API reference For AI assistants